Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 32,900
-1,000 (-2.95%)
Last updated: Sep 9, 2025, 9:33 AM KST
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 1.72 trillion as of September 8, 2025. Its market cap has decreased by -4.39% in one year.
Market Cap
1.72T
Enterprise Value
1.71T
Revenue
150.09B
Ranking
n/a
PE Ratio
770.43
Stock Price
32,900.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 1.72T, an increase of 6,442.34%. That is a compound annual growth rate of 14.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 1,720.59B | -12.21% |
| Dec 30, 2024 | 1,959.95B | -12.72% |
| Dec 28, 2023 | 2,245.71B | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1,077.89B | -43.84% |
| Dec 30, 2020 | 1,919.22B | 3.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.38T |
| Celltrion | 37.45T |
| ALTEOGEN | 25.54T |
| Yuhan | 9,104.15B |
| SK Biopharmaceuticals | 8,575.30B |
| PharmaResearch | 7,013.01B |
| Peptron | 6,756.23B |
| LigaChem Biosciences | 5,523.68B |